Nanotechnology May Lead To New Treatment Of Liver Cancer
2/24/2011
Nanotechnology may open a new door on the treatment of liver cancer, according to a team of Penn State College of Medicine researchers. They used molecular-sized bubbles filled with chemotherapy drugs to prevent cell growth and initiate cell death in test tubes and mice. Researchers evaluated the use of molecular-sized bubbles filled with C6-ceramide, called cerasomes, as an anti-cancer agent...
The National Institute for Health and Clinical Excellence (NICE) has today (23 February) published final guidance to the NHS not recommending the use of bevacizumab (Avastin, Roche Products), when used in combination with a taxane (a type of chemotherapy drug), as a first-line treatment for people with metastatic breast cancer...
Compound Used To Block Cholesterol Could Also Kill Breast Cancer, MU Researcher Finds
2/24/2011
A University of Missouri researcher believes there could be a new drug compound that could kill breast cancer cells. The compound might also help with controlling cholesterol...
The American Society of Clinical Oncology (ASCO) issued an update to its clinical practice guideline on the use of bone-modifying agents, in particular, osteoclast inhibitors, to prevent and treat skeletal complications from bone metastases in patients with metastatic breast cancer...
New Treatment To Benefit Certain Patients With Leukaemia Thanks To New NICE Guidance
2/24/2011
The National Institute for Health and Clinical Excellence (NICE) has published final guidance to the NHS recommending the use of a new treatment that can help extend the lives of certain people with the most common form of leukaemia...
Mammograms More Effective At Catching First Than Second Breast Cancers Early
2/23/2011
Mammograms are effective at catching breast cancers early in women with a personal history of the disease, but not as effective as they are in women with no such history, according to the findings of what has been termed the most comprehensive relevant study of the effectiveness of annual screening for breast cancer survivors...
Women Have Options For Colorectal Cancer Screenings
2/23/2011
Although colonoscopy is the preferred method of screening for colorectal cancer, physicians should discuss all screening options with their patients, according to a new Committee Opinion released today by The American College of Obstetricians and Gynecologists. Women should be screened using the method that they are most comfortable with and most likely to complete...
Markers Of Bladder Cancer Risk May Be Revealed By Blood Test
2/23/2011
Knowing that it is impossible to catalog all the carcinogenic exposures a person has had in life and then assess them, Brown University researcher Carmen Marsit is looking for a more precise way to predict individual susceptibility to cancer. In a paper published online Feb...
Immune System Natural Killer Cells: What Do They Really Do?
2/23/2011
Our immune systems contain three fundamentally different types of cell: B-cells, T-cells and the mysteriously named Natural Killer cells (NK cells), which are known to be involved in killing tumour cells and other infected cells...
Amgen (Nasdaq: AMGN) announced the publication of results from a pivotal Phase 3 study of 1,776 advanced cancer patients with different types of solid tumors (not including breast and prostate cancer) or multiple myeloma, which compared XGEVA™ (denosumab) to Zometa® (zoledronic acid) in preventing skeletal-related events (SREs)...